Jhansi Dyavanapalli

Jhansi Dyavanapalli Ph.D is an experienced professional in the field of life sciences, currently serving as a Manager/Scientist in Quality Control Molecular Cell Therapy at Bristol Myers Squibb since July 2021. With a robust background in immunology and cell culture methodologies such as flow cytometry, PCR, and ELISA, Jhansi has effectively managed QC Analytical Laboratory Operations supporting cell therapy drug product development and testing. Prior roles include Senior Research Scientist in Neuroscience at The George Washington University School of Medicine and Health Sciences, where Jhansi led drug development strategies resulting in a novel heart failure treatment and significant funding accomplishments. Jhansi has also held positions at The George Washington University and the University of Dundee, accumulating extensive research experience, including contributions to multiple publications and scientific presentations. Educational qualifications include a Ph.D. in Life Sciences from the University of Dundee and a Master's degree in Pharmacology and Biotechnology from Sheffield Hallam University.